HOME >> MEDICINE >> NEWS
The Lancet Oncology (TLO) and the Lancet Infectious Diseases (TLID)

This month's Leading Edge editorial discusses the difference between perception of risk and the actual risk by drawing upon two recent examples: breast cancer and the pill, and cannabis smoking and cancer risk. In both situations, scientific evidence does not appear to be affecting the public's misperception of absolute risk, and more worryingly, in the case of cannabis smoking, even nationwide policy is being lead by personal views rather than scientific evidence.

The editorial concludes: "Unravelling a misguided perception of risk from the real facts is a difficult task, but it is essential if the perpetuation of poorly conceived ideas is to stop. In light of the current trend towards chemoprevention to reduce a person's risk of contracting cancer, it is important that the general public do not become disenfranchised from the medical community by exposure to over-reporting of contradictory reports in the popular media. Only then will cancer risk truly decrease by informed changes in lifestyle."

Reviews:

Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention

Cigarette smoking and the risk of endometrial cancer

Strategic marketing in the UK tobacco industry

Hyperthermia in combined treatment of cancer

Metastasis to and from the central nervous system-the "relatively protected site"

Stem-cell origin of metastasis and heterogeneity of solid tumours

The Lancet Infectious Diseases (TLID)

Combination antiretroviral therapies are widely used for the treatment of HIV but it is unclear whether they will continue to be effective in the face of quickly evolved drug-resistant strains of HIV, and increased risky sexual behaviour in certain communities. In the August issue of The Lancet Infectious Diseases, J X Velasco-Hernandez and colleagues, from the Instituto Mexicano del Petroleo, San Bartolo, Mexico, and the UCLA School of Medicine, Los Angeles, US
'"/>

Contact: Richard Lane
richard.lane@lancet.com
44-20-7424-4949
Lancet
31-Jul-2002


Page: 1 2

Related medicine news :

1. The Lancet calls for the creation of a world institute for risk evaluation
2. The Lancet calls for creation of Intl Commission on Global Responses to Complex Emergencies
3. Majority of authors retract 1998 Lancet paper-Lancet editor points to implications
4. The Lancet Oncology (TLO)
5. The Lancet Infectious Diseases (TLID)
6. The Lancet Neurology November press release
7. Lancet readers to join WHO election debate
8. The Lancet Oncology press release
9. The Lancet Neurology October press release
10. The Lancet neurology press release
11. The Lancet Neurology press release

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/6/2019)... (PRWEB) , ... December 06, 2019 , ... ... recruiting, has been recognized for excellence in employee learning. The Omaha-based company has ... ranks organizations with the most successful employer-sponsored training and development programs worldwide. Rankings ...
(Date:12/6/2019)... ... December 06, 2019 , ... Allegheny Health Network (AHN) ... Gyure, who joined AHN from WVU Medicine in May 2018, previously served as AHN’s ... served as interim chair since October and is also part of the pathology faculty ...
(Date:12/6/2019)... ... December 06, 2019 , ... TIME For Kids (TFK) revealed the ... educational, innovative, and fun destinations that are tailored to the interests of kids. The ... , To assemble the list, TIME for Kids gathered nominations from its network of ...
(Date:12/5/2019)... Conn. (PRWEB) , ... December 05, 2019 , ... ... Physician Practice M&A: Risks and Rewards of Building Platforms— on Thursday, December 12, ... are competing for large, multi-specialty medical groups. Middle-market PE firms are scrambling to ...
(Date:12/4/2019)... , ... December 04, 2019 , ... A November 12 ... more cities offer them as public transit options. The article highlighted the life-changing or ... now confined to a bed to a rider fatality after an incident with a ...
Breaking Medicine News(10 mins):
(Date:12/9/2019)... ... December 09, 2019 , ... American Pharmaceutical Review, ... America has released its documentary on " Making Data Work: Leveraging Data for ... companies are currently using data to produce products, and how they can leverage ...
(Date:12/9/2019)... N.Y. (PRWEB) , ... December 09, 2019 , ... ... “The cysts most people contend with are not ‘sebaceous,’” notes Dr. Robert Levine, ... are usually epidermoid – also called ‘epidermal’ – cysts, which have their own ...
(Date:12/8/2019)... ... December 07, 2019 , ... ... affairs, regulatory, and technology-enabled solutions, announced that MAIA Pharmaceuticals, Inc. (MAIA), a specialty ... has chosen Soterius and its partners in Europe, to support their regulatory strategy ...
Breaking Medicine Technology:
Cached News: